Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
| 대상 질환 | Alzheimer's Disease |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Icahn School of Medicine at Mount Sinai |
| 상태 | 완료 |
| 참여자 수 | 14 명 |
| 중재(약물) | Active lighting intervention, Control lighting intervention |
| 시작일 | 2022년 1월 6일 |
| 완료일 | 2023년 5월 1일 |
| 결과 공개일 | 2026년 7월 30일 |
요약
To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Sleep Disturbance Using the Pittsburgh Sleep Quality Index (PSQI)
| Active Lighting Intervention | 6.5 ± 4.3 Score on a scale |
|---|---|
| Control Lighting | 4 ± 2.3 Score on a scale |
| Active Lighting Intervention | 4.1 ± 2.3 Score on a scale |
| Control Lighting | 6 ± 3.3 Score on a scale |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University